Cure HHT Participates in PHA’s Associated Conditions Summit

Individuals with HHT have a greater risk of developing pulmonary hypertension. Statistically, 15-20% of HHT patients have PH. In November 2021, Cure HHT participated in the The Pulmonary Hypertension Association (PHA) Associated Conditions Partner Summit to explore ways to improve the understanding of PH and reduce barriers to diagnosis among at-risk groups, including those with HHT who may also unknowingly suffer from PH. In the inaugural five-hour summit, PHA staff and volunteers engaged with representatives from organizations that focus on conditions associated with PH. Learn more about the summit.